Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-28

Yes ITSA all good but if you expect that the Diamond with his level of neglectable professional knowledge, lack of network in the bio/pharma field and the fact he due to his lack of management skill he has to follow the advice of XEC/Koutchin you are dreaming. I really hoped that having Ms. C. Gittleson as chair something would have changed but it seems she completely disappeared from the radar same as apparently ANP did in the bio world except in some Singaporean restaurants
We need a real good strong shake up at management level.